Good Sam

Season 1 Episode 11

Family/Business

Good Sam S1E11 supports one concrete transplant case: Chloe's cystic-fibrosis lung-lobe transplant with Yolanda as a living donor.

Air date: Apr 20, 2022

diagnostic realism

3.5/5

overall

3.7/5

procedure realism

3.7/5

workflow realism

3.8/5

Medical Cases in This Episode

These are the patient stories worth unpacking. Open any case for the real-world medicine, what the episode shows, what it leaves out, and source-backed context.

1 case identified

Case 1

Chloe: Cystic Fibrosis and Living-Donor Lung-Lobe Transplant

Chloe's planned living-donor lung-lobe transplant is delayed when donor Yolanda develops fever and later admits ecstasy use.

Episode shows
Apple TV, Rotten Tomatoes, FilmBook, and iDRief all identify the episode's major medical event as a high-stakes lung transplant. Celeb Dirty Laundry's recap names Chloe as a cystic fibrosis patient, identifies Yolanda as her best friend and donor, says the tra...
Clinical takeaway
This case is useful for explaining transplant readiness in advanced cystic fibrosis, living-donor lung-lobe donation, infectious-risk screening, substance exposure concerns, and why donor changes can endanger recipient timing.
Accuracy 3.7/5cystic-fibrosislung-transplantliving-donor-transplant

Episode Summary

Family/Business centers its confirmed medical story on Chloe, a cystic fibrosis patient whose planned living-donor lung-lobe transplant depends on Yolanda's donor fitness. Public episode sources support the transplant setup, donor fever concern, Chloe's clinical worsening, and the team's reassessment after Yolanda discloses ecstasy use.

Medical Accuracy Review

The episode gets several broad points right: cystic fibrosis can progress to transplant-level lung disease, donor illness can delay transplant surgery, and respiratory status can worsen while a patient waits. Living-donor lung-lobe transplant is real but rare and complex.

The compressed part is the decision to proceed after Yolanda's fever and ecstasy disclosure. Real teams would need more documented evidence about infection risk, donor safety, consent, anatomy, toxicology relevance, recipient urgency, and post-operative planning.

Educational Disclaimer

This iDRief review is for general education and television analysis only. It is not medical advice, diagnosis, or treatment guidance. Anyone with questions about cystic fibrosis, organ donation, lung transplant, donor eligibility, or breathing symptoms should consult qualified clinicians or transplant-center staff.